3
Shared Docs
3
Same-Page
3 / 3
Mentions
both the IPR decision and the lower court ruling can be appealed. Amanda Ens EFTA00820342 Director Bank of America Merrill Lynch Merrill Lynch, Pierce, Fenner & Smith Incorporated The power of global connectionsTM From: Ens, Amanda Sent: Wednesday, August 24, 2016 3:30 PM To: 'Richard Kahn' Subject: RE: TEVA...IPR Decision
den of proof is on the generics). Also note that the traditional P-IV challenge from MNTA/Sandoz/MYL/Amneal/Synthon/PFE/DRRD will kick off 26-Sep. 4 Net/net, a victory for TEVA likely sees a 10%+ move higher in my view (S58ish) while a negative outcome likely sees 5% downside to around $50/sh (given
both the IPR decision and the lower court ruling can be appealed. EFTA00820351 Amanda Ens Director Bank of America Merrill Lynch Merrill Lynch, Pierce, Fenner & Smith Incorporated The power of global connections"' From: Ens, Amanda Sent: Wednesday, August 24, 2016 3:30 PM To: 'Richard Kahn' Subject: RE: TEVA...IPR Decision
rden of proof is on the generics). Also note that the traditional P-IV challenge from MNTA/Sandoz/MYL/AmneaUSynthon/PFE/DRRD will kick off 26-Sep. 4 Net/net, a victory for TEVA likely sees a 10%+ move higher in my view (S58ish) while a negative outcome likely sees 5% downside to around $50/sh (given
. We note that both the IPR decision and the lower court ruling can be appealed. Amanda Ens Director Bank of America Merrill Lynch Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park, 5th Floor, New York, NY 10036 Phone: Mobile: The power of global connectionsTM From: Ens, Amanda Sent: Wednesday, August 24, 2
den of proof is on the generics). Also note that the traditional P-IV challenge from MNTA/Sandoz/MYL/Amneal/Synthon/PFE/DRRD will kick off 26-Sep. 4 Net/net, a victory for TEVA likely sees a 10%+ move higher in my view (S58ish) while a negative outcome likely sees 5% downside to around $50/sh (given
Entities connected to both Pierce, Fenner & Smith Incorporated and 4 Net

Jeffrey Epstein
PERSON
Richard Kahn
PERSONAmanda
PERSONAmanda Ens
PERSON
Marc Rich
PERSONCopaxone
ORGANIZATIONSector Specialist Sales
ORGANIZATIONCopaxone 3TW
ORGANIZATIONDaniel Lundquist
PERSONHealthcare Specialist Sales
ORGANIZATIONSynthon/Pfizer
ORGANIZATIONCopaxone Copaxone US
ORGANIZATIONIP &
ORGANIZATIONMNTA/Sandoz/MYL
ORGANIZATIONCopaxone Litigation Timeline
ORGANIZATIONEpiPen
ORGANIZATIONReddy
LOCATIONSumant
ORGANIZATION
Mylan
ORGANIZATIONTEVVF Pfd
ORGANIZATION